Projects per year
Personal profile
External positions
Member EAN scientific panel, European Academy of Neurology
18 Nov 2021 → …
Expert member SAG Neurology, European Medicines Agency
1 Aug 2021 → …
PhD, Neuroimmunology Unit, Division of Neurology, Karolinska Institute, Huddinge University Hospital, Stockholm, Sweden.
1998 → 2001
Keywords
- R Medicine (General)
- Neurology
- Neuro-oncology
- AYA (Adolescents and Young Adults) with cancer
- RM Therapeutics. Pharmacology
- Clinical pharmacology
- Treatment Efficacy
- Toxicity
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 1 Active
-
GLIOCARE
Keil, V., Wamelink, I., Azizova, A., Barkhof, F., Mutsaerts, H., Petr, J., de Witt Hamer, P., Wesseling, P. & Kouwenhoven, M.
1/04/2022 → …
Project: Research
-
SEVERE HEMATOLOGICAL TOXICITY DURING CHEMORADIATION FOR GLIOBLASTOMA: IDENTIFICATION OF CLINICAL AND PHARMACOLOGICAL RISK FACTORS AND CONSEQUENCES FOR THE INDIVIDUAL PATIENT
Grun, N., den Otter, C. A., Sintemaartensdijk, M., Osinga, J., van den Elzen, F. E. L., van der Vegt, A. N., de Haan, J., Bruynzeel, A. M. E., van Linde, M. E., Postma, T. J., Schuur, M., Hamer, P. C. D. W., De Vos, F. Y. F. L., Verhoeff, J. J. C., Jongen, J. L. M., Lissenberg-Witte, B. I. & Kouwenhoven, M. C. M., Sept 2021, In: Neuro-oncology. 23, p. 40-40Research output: Contribution to journal › Meeting Abstract › Academic
-
ABSENCE OF SEVERE HEMATOLOGICAL TOXICITY DURING FIRST LINE TREATMENT PREDICTS LOW CHANCE ON SEVERE TOXICITY DURING SECOND LINE ALKYLATING CHEMOTHERAPY IN GLIOBLASTOMA
van den Elzen, F. E. L., Grun, N., Osinga, J., van der Vegt, A. N., de Glopper, L., Sintemaartensdijk, M., van Linde, M. E., Postma, T. J., Schuur, M. & Kouwenhoven, M. C. M., Sept 2021, In: Neuro-oncology. 23, p. 8-8Research output: Contribution to journal › Meeting Abstract › Academic
-
Cannabinoids to Improve Health-Related Quality of Life in Patients with Neurological or Oncological Disease: A Meta-Analysis
Belgers, V., Röttgering, J. G., Douw, L., Klein, M., Ket, J. C. F., van de Ven, P. M., Würdinger, T., van Linde, M. E., Niers, J. M., Weber, M., Olde Rikkert, M. G., Lopez-Sendon, J., Arrieta, O., Svendsen, K. B., Chagas, M. H. N., de Almeida, C. M. O., Kouwenhoven, M. C. M. & de Witt Hamer, P. C., 1 Feb 2023, In: Cannabis and cannabinoid research. 8, 1, p. 41-55 15 p.Research output: Contribution to journal › Review article › Academic › peer-review
Open Access -
Effectiveness of Antiseizure Medication Triple Therapy in Patients with Glioma with Refractory Epilepsy: An Observational Cohort Study
van der Meer, P. B., Dirven, L., Fiocco, M., Vos, M. J., Kouwenhoven, M. C. M., van den Bent, M. J., Taphoorn, M. J. B. & Koekkoek, J. A. F., 4 Apr 2023, In: Neurology. 100, 14, p. E1488-E1496Research output: Contribution to journal › Article › Academic › peer-review
Open Access -
Frequency and burden of potentially treatable symptoms in glioma patients with stable disease
Röttgering, J. G., Belgers, V., Kouwenhoven, M. C. M., Schuur, M., Postma, T. J., Nijboer, C. M., van Linde, M. E., de Witt Hamer, P. C., Douw, L. & Klein, M., 1 Feb 2023, In: Heliyon. 9, 2, e13278.Research output: Contribution to journal › Article › Academic › peer-review
Open Access
-
European Medicines Agency (External organisation)
Mathilde Kouwenhoven (Chair)
24 May 2021 → …Activity: Membership › Membership of committee › Academic
-
Prognostication and surgical management of diffuse gliomas in the era of molecular diagnostics
Mathilde Kouwenhoven (Examiner)
28 May 2019Activity: Examination › Educational
-
Het incidentaloom, bijvangst van de moderne geneeskunde.
Mathilde Kouwenhoven (Speaker)
15 Mar 2019Activity: Talk or presentation › Invited talk › Academic
-
Landelijke Werkgroep Neuro-oncologie (External organisation)
Mathilde Kouwenhoven (Chair)
2018 → …Activity: Membership › Membership of committee › Academic
-
American Academy of Neurology (External organisation)
Mathilde Kouwenhoven (Chair)
2018 → …Activity: Membership › Membership of network › Professional